Biotech Values

[DewDiligence]

Recent Biotech Buyouts at a Large Premium

  
 Acquired         Premium    Deal         iHub 
 Company  Buyer   to market  value  Date  Reference 
 KOSN     BMY       233%     $190M  5/08  #msg-29647147 
 COLY     PFE       167%     $165M 11/07  #msg-24600805 
 IOMI     Intercell 147%     $190M  5/08  #msg-29232165 
 TRC      Ipsen     104%     $660M  6/08  #msg-29795183 
 SIRT     GSK        85%     $620M  4/08  #msg-28705020 
 MLNM     Takeda     53%     $8.8B  4/08  #msg-28365383

Let’s talk biotech!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”